Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate

被引:235
作者
Dube, Admire [1 ]
Nicolazzo, Joseph A. [1 ]
Larson, Ian [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
关键词
Green tea; (+)-Catechin; (-)-Epigallocatechin gallate; Chitosan nanoparticles; Ussing chamber; Apparent permeability; Intestinal absorption enhancement; IN-VITRO; EPIGALLOCATECHIN GALLATE; ORAL BIOAVAILABILITY; PERMEABILITY; POLYPHENOLS; CONSUMPTION; DELIVERY; HEALTH; METABOLISM; MECHANISMS;
D O I
10.1016/j.ejps.2010.06.010
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Catechins found in green tea have received considerable attention due to their favourable biological properties which include cardioprotective, neuroprotective and anti-cancer effects. However, their therapeutic potential is limited by their low oral bioavailability, attributed to poor stability and intestinal absorption. We encapsulated (+)-catechin (C) and (-)-epigallocatechin gallate (EGCg) in chitosan nanoparticles (CS NP) as a means of enhancing their intestinal absorption. Using excised mouse jejunum in Ussing chambers, encapsulation significantly enhanced (p < 0.05) intestinal absorption. The cumulative amounts transported after encapsulation were significantly higher (p < 0.05), i.e. 302.1 +/- 46.1 vs 206.8 +/- 12.6 ng/cm(2) and 102.7 +/- 12.4 vs 57.9 +/- 7.9 ng/cm(2) for C and EGCg, respectively. The mechanism by which absorption was enhanced was not through an effect of CS NPs on intestinal paracellular or passive transcellular transport processes (as shown by transport of C-14-mannitol and H-3-propranolol) or an effect on efflux proteins (as shown by transport of H-3-digoxin) but was likely due to stabilization of catechins after encapsulation (99.7 +/- 0.7 vs 94.9 +/- 3.8% and 56.9 +/- 3.0 vs 1.3 +/- 1.7% of the initial C and EGCg concentration remaining, respectively). This study demonstrates that encapsulation of catechins in CS NPs enhances their intestinal absorption and is a promising strategy for improving their bioavailability. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 39 条
[1]
Arai K., 1968, B TOKAI REG FISH RES, V56, P89, DOI [10.3390/md12126236, DOI 10.3390/MD12126236]
[2]
Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States) [J].
Arts, ICW ;
Jacobs Jr, DR ;
Gross, M ;
Harnack, LJ ;
Folsom, AR .
CANCER CAUSES & CONTROL, 2002, 13 (04) :373-382
[3]
Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
[4]
Arts ICW, 2001, AM J CLIN NUTR, V74, P227
[5]
Synthesis and characterization of PLGA nanoparticles [J].
Astete, Carlos E. ;
Sabliov, Cristina M. .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2006, 17 (03) :247-289
[6]
The chemistry of tea flavonoids [J].
Balentine, DA ;
Wiseman, SA ;
Bouwens, LCM .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 1997, 37 (08) :693-704
[7]
Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats [J].
Cai, Y ;
Anavy, ND ;
Chow, HHS .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (11) :1246-1249
[8]
Flavonoids: Prospective Drug Candidates [J].
Cazarolli, Luisa Helena ;
Zanatta, Leila ;
Alberton, Elga Heloisa ;
Reis Bonorino Figueiredo, Maria Santos ;
Folador, Poliane ;
Damazio, Rosangela Guollo ;
Pizzolatti, Moacir Geraldo ;
Mena Barreto Silva, Fatima Regina .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (13) :1429-1440
[9]
Chow HHS, 2003, CLIN CANCER RES, V9, P3312
[10]
Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53